STOCK Act, US House only, disclosed up to 45 days after the trade
Funds added, last quarter
220
13F, latest reported quarter
What the filings say about MC
Insiders, 180 days
-$466.0K net sold
2 sellers · 0% of sales under a 10b5-1 plan
Planned sales (Form 144), 90 days
$466.0K
2 notices
Moelis & Co insider trades (Form 4)
Form 4 buys and sells (codes P and S). Grants, option exercises
and conversions excluded.
Over the last 180 days, Moelis & Co insiders sold a net $466.0K of stock across 103 Form 4 purchases and sales, with no insider buying. Source: SEC Form 4 filings, as of 2026-10-27.
5 earlier Form 4 trades (code P or S) here by this insider (5 sales), the last on Aug 22, 2025.
The trade is 24.6% of the 7,633 shares held after it.
1 other insider sold within 30 days.
220 funds added in the 13F quarter to Jun 30, 2026.
Insider activity: Director Shropshire Kenneth sold about $129.9K of MC on Aug 27, 2026; 1 other insider sold within 30 days and 220 funds added in the latest 13F quarter.
9 earlier Form 4 trades (code P or S) here by this insider (9 sales), the last on Feb 19, 2026.
The trade is 3702.3% of the 131 shares held after it.
1 other insider sold within 30 days.
220 funds added in the 13F quarter to Jun 30, 2026.
Insider activity: General Counsel, Secretary WATANABE OSAMU R. sold about $336.1K of MC on Aug 4, 2026, the largest insider sale at the company since 2025; 1 other insider sold within 30 days and 220 funds added in the latest 13F quarter.
4 earlier Form 4 trades (code P or S) here by this insider (4 sales), the last on Feb 21, 2025.
The trade is 36.8% of the 7,109 shares held after it.
1 other insider sold within 30 days.
220 funds added in the 13F quarter to Jun 30, 2026.
Insider activity: Director Shropshire Kenneth sold about $189.6K of MC on Aug 22, 2025; 1 other insider sold within 30 days and 220 funds added in the latest 13F quarter.
7 earlier Form 4 trades (code P or S) here by this insider (7 sales), the last on Feb 19, 2025.
The trade is 4839.7% of the 131 shares held after it.
1 other insider sold within 30 days.
220 funds added in the 13F quarter to Jun 30, 2026.
Insider activity: General Counsel, Secretary WATANABE OSAMU R. sold about $460.5K of MC on Jul 25, 2025; 1 other insider sold within 30 days and 220 funds added in the latest 13F quarter.
103 transactions on record
Since filing: total return from the first close after the filing to the latest close, dividend-adjusted. Not a forecast.
Context lines are counts over the filings above and returns from our own price history, never a price level. Not investment advice.
Nobody has filed for crossing 5%. That is a fact, not missing data.
MC planned insider sales (Form 144)
Notice of intent to sell, filed before any sale
KENNETH SHROPSHIRE
Filed 2026-08-27
$129.9K
OSAMU R WATANABE
Filed 2026-08-04
$336.1K
MC mutual fund holders (N-PORT)
Funds ranked by the share of their own portfolio in this stock (N-PORT).
Touchstone Funds Group Trust-Touchstone Small Cap Fund
$11.2M position · as of 2026-06-30
4.4%
Wasatch Long/Short Alpha Fund
$1.4M position · as of 2026-06-30
3.6%
Virtus KAR Small-Cap Core Fund
$62.3M position · as of 2026-06-30
3.4%
Madison Mid Cap Fund
$50.5M position · as of 2026-07-31
2.9%
Mid Cap Fund
$3.0M position · as of 2026-06-30
2.9%
Touchstone Funds Group Trust-Touchstone Mid Cap Fund
$127.9M position · as of 2026-06-30
2.8%
SEC N-PORT, monthly, about 60 days late · funds ≥ $10M ·
% is the share of the fund's own portfolio
Executive pay vs shareholder return · Kenneth Moelis
CEO pay, headline and as actually paid, against the company's
return and its chosen peers' (DEF 14A).
FY
CEO total
Actually paid
Other execs, avg
TSR
Peer TSR
2024
$7.6M
$18.7M
$5.0M
+105%
+77%
2023
$7.9M
$22.1M
$5.9M
+50%
+35%
2022
$19.2M
$7.5M
$6.9M
-3%
+21%
2021
$14.4M
$24.4M
$9.7M
+49%
+35%
2020
$9.9M
$17.6M
$5.5M
+63%
-2%
Tagged by the company under SEC Item 402(v). Returns are
cumulative from the start of the disclosure period. Green where the company beat its own peer group.
Live price
Daily candles from TradingView, under their licence. No filings marked.
Why this name is on the desk
Insiders have filed to sell, before selling.
The record shows a net $466.0K sold by insiders over 180 days, 220 funds added last quarter, $466.0K in planned Form 144 sales. Each figure is a federal filing, dated the day it went public.
Ratios from the company's XBRL filings, latest filings
Revenue, TTM
n/a
fewer than four consecutive quarters of revenue filed
Revenue, TTM MC
FY Dec 2025
n/a
FY Dec 2024
n/a
FY Dec 2023
n/a
FY Dec 2022
n/a
FY Dec 2021
n/a
Jun 2026
n/a
Mar 2026
n/a
Dec 2025
n/a
Sep 2025
n/a
Jun 2025
n/a
Mar 2025
n/a
Dec 2024
n/a
Sep 2024
n/a
At each fiscal year end
Single quarter
Net margin, TTM
n/a
needs four consecutive quarters of both revenue and net income
Net margin, TTM MC
FY Dec 2025
n/a
FY Dec 2024
n/a
FY Dec 2023
n/a
FY Dec 2022
n/a
FY Dec 2021
n/a
Jun 2026
n/a
Mar 2026
n/a
Dec 2025
n/a
Sep 2025
n/a
Jun 2025
n/a
Mar 2025
n/a
Dec 2024
n/a
Sep 2024
n/a
At each fiscal year end
Single quarter
Free cash flow, TTM
$433.4M
operating cash flow minus capex, 2025-07-01 to 2026-06-30
Free cash flow, TTM MC
FY Dec 2025
$540.0M
FY Dec 2024
$415.4M
FY Dec 2023
$141.8M
FY Dec 2022
$27.0M
FY Dec 2021
$920.6M
Jun 2026
$215.9M
Mar 2026
-$291.6M
Dec 2025
$329.6M
Sep 2025
$179.6M
Jun 2025
$199.4M
Mar 2025
-$168.6M
Dec 2024
$313.0M
Sep 2024
$135.1M
At each fiscal year end
Single quarter
Debt to equity
n/a
no debt line filed
Debt to equity MC
FY Dec 2025
n/a
FY Dec 2024
n/a
FY Dec 2023
n/a
FY Dec 2022
n/a
FY Dec 2021
n/a
Jun 2026
n/a
Mar 2026
n/a
Dec 2025
n/a
Sep 2025
n/a
Jun 2025
n/a
Mar 2025
n/a
Dec 2024
n/a
Sep 2024
n/a
At each fiscal year end
Trailing four quarters at each quarter end
Cash flow to debt
n/a
no debt line filed
Cash flow to debt MC
FY Dec 2025
n/a
FY Dec 2024
n/a
FY Dec 2023
n/a
FY Dec 2022
n/a
FY Dec 2021
n/a
Jun 2026
n/a
Mar 2026
n/a
Dec 2025
n/a
Sep 2025
n/a
Jun 2025
n/a
Mar 2025
n/a
Dec 2024
n/a
Sep 2024
n/a
At each fiscal year end
Trailing four quarters at each quarter end
Return on equity
+50.2%
TTM net income over average of 2025-06-30 and 2026-06-30
Return on equity MC
FY Dec 2025
+51.4%
FY Dec 2024
+38.2%
FY Dec 2023
-6.9%
FY Dec 2022
+36.1%
FY Dec 2021
+87.3%
Jun 2026
+50.2%
Mar 2026
+51.1%
Dec 2025
+51.4%
Sep 2025
+57.7%
Jun 2025
+50.3%
Mar 2025
+44.2%
Dec 2024
+38.2%
Sep 2024
+12.3%
At each fiscal year end
Trailing four quarters at each quarter end
Return on assets
+18.7%
TTM net income over average of 2025-06-30 and 2026-06-30
Return on assets MC
FY Dec 2025
+16.6%
FY Dec 2024
+11.8%
FY Dec 2023
-2.3%
FY Dec 2022
+12.2%
FY Dec 2021
+30.7%
Jun 2026
+18.7%
Mar 2026
+19.9%
Dec 2025
+16.6%
Sep 2025
+19.5%
Jun 2025
+18.4%
Mar 2025
+16.9%
Dec 2024
+11.8%
Sep 2024
+4.0%
At each fiscal year end
Trailing four quarters at each quarter end
Return on invested capital
n/a
no debt line filed
Return on invested capital MC
FY Dec 2025
n/a
FY Dec 2024
n/a
FY Dec 2023
n/a
FY Dec 2022
n/a
FY Dec 2021
n/a
Jun 2026
n/a
Mar 2026
n/a
Dec 2025
n/a
Sep 2025
n/a
Jun 2025
n/a
Mar 2025
n/a
Dec 2024
n/a
Sep 2024
n/a
At each fiscal year end
Trailing four quarters at each quarter end
Return on capital employed
n/a
assets or current liabilities not filed
Return on capital employed MC
FY Dec 2025
n/a
FY Dec 2024
n/a
FY Dec 2023
n/a
FY Dec 2022
n/a
FY Dec 2021
n/a
Jun 2026
n/a
Mar 2026
n/a
Dec 2025
n/a
Sep 2025
n/a
Jun 2025
n/a
Mar 2025
n/a
Dec 2024
n/a
Sep 2024
n/a
At each fiscal year end
Trailing four quarters at each quarter end
P/E, trailing
n/a
fewer than four consecutive quarters of diluted EPS
P/E, trailing MC
FY Dec 2025
n/a
FY Dec 2024
n/a
FY Dec 2023
n/a
FY Dec 2022
n/a
FY Dec 2021
n/a
Jun 2026
n/a
Mar 2026
n/a
Dec 2025
n/a
Sep 2025
n/a
Jun 2025
n/a
Mar 2025
n/a
Dec 2024
n/a
Sep 2024
n/a
At each fiscal year end
Trailing four quarters at each quarter end
Enterprise value
n/a
no share count filed
Enterprise value MC
FY Dec 2025
n/a
FY Dec 2024
n/a
FY Dec 2023
n/a
FY Dec 2022
n/a
FY Dec 2021
n/a
Jun 2026
n/a
Mar 2026
n/a
Dec 2025
n/a
Sep 2025
n/a
Jun 2025
n/a
Mar 2025
n/a
Dec 2024
n/a
Sep 2024
n/a
At each fiscal year end
Trailing four quarters at each quarter end
FCF yield
n/a
no share count filed
FCF yield MC
FY Dec 2025
n/a
FY Dec 2024
n/a
FY Dec 2023
n/a
FY Dec 2022
n/a
FY Dec 2021
n/a
Jun 2026
n/a
Mar 2026
n/a
Dec 2025
n/a
Sep 2025
n/a
Jun 2025
n/a
Mar 2025
n/a
Dec 2024
n/a
Sep 2024
n/a
At each fiscal year end
Trailing four quarters at each quarter end
PEG, trailing
n/a
fewer than four consecutive quarters of diluted EPS
PEG, trailing MC
FY Dec 2025
n/a
FY Dec 2024
n/a
FY Dec 2023
n/a
FY Dec 2022
n/a
FY Dec 2021
n/a
Jun 2026
n/a
Mar 2026
n/a
Dec 2025
n/a
Sep 2025
n/a
Jun 2025
n/a
Mar 2025
n/a
Dec 2024
n/a
Sep 2024
n/a
At each fiscal year end
Trailing four quarters at each quarter end
Price as of 2026-10-23. Hover or tap a tile for its yearly and quarterly history.Method
TTM is four consecutive fiscal quarters; Q4 is the year minus nine months when not filed. Returns use the average of opening and closing balances. EBIT is approximated by operating income. PEG uses trailing EPS growth.
Fundamentals
Annual figures from XBRL filings. Pick a past date to see them as known then.
MC ranks highest on profitability (92nd percentile) and institutional and government (78th), and lowest on risk and compliance (27th), among Financial Services peers.
Profitability
92
Inputs
Return on equity+50.2% · 95 pct, sector of 205
Return on assets+18.7% · 90 pct, sector of 266
Return on invested capitalno debt line filed
Return on capital employedassets or current liabilities not filed
Insider conviction
28
Inputs
Net Form 4 buying (codes P and S), 180d-$466K · 56 pct, sector of 161
Insider buyers, 180d0 · 0 pct, sector of 165
Institutional and government
78
Inputs
Funds adding, latest quarter220 · 78 pct, sector of 278
Congress net buyers, 365dno Congress trades in 365 days
Federal contracts, 180dno federal contracts in 180 days
Lobbying spend, 4 quartersno lobbying filings in the last four quarters
Risk and compliance
27
Inputs
Short interest, % of float+7.2% · 27 pct, sector of 390
Recalls per $1B revenue, 3yrevenue under $50M or not filed, so a count cannot be scaled to size
EPA cases per $1B revenue, 5yrevenue under $50M or not filed, so a count cannot be scaled to size
New text in Risk Factors, latest 10-Kneeds two 10-Ks with a Risk Factors section (not 20-F filers or stubs)
3 not measured: Financial health, Growth, US patents
Financial health needs 1 of 2 inputs, 0 present: no debt line filed
Growth needs 1 of 2 inputs, 0 present: no backlog line filed, or no year-earlier backlog; no revenue for this year and the year before
US patents needs 1 of 2 inputs, 0 present: patent data not loaded yet
4 of 7 axes scored. Each is a percentile against sector peers (all companies when the sector is thin); higher is better. An unscored axis is unmeasured, not low. How it is scored
MC filings, in plain words
Are Moelis & Co insiders buying or selling MC?
In the 180 days to 2026-10-27, Moelis & Co insiders were net sellers, a net $466.0K across purchases and sales reported on Form 4, by 2 sellers.
Are there planned insider sales of MC?
Yes. 2 Form 144 notices of planned insider sales were filed in the 90 days to 2026-10-27, covering $466.0K of stock; the latest, by KENNETH SHROPSHIRE, was filed 2026-08-27.
Read the full summary
In the 180 days to 2026-10-27, Moelis & Co insiders were net sellers of MC, a net $466.0K across purchases and sales reported on Form 4 by 2 sellers. Insiders filed 2 Form 144 notices of intent to sell in the 90 days to 2026-10-27, covering $466.0K of stock. Each figure is counted from SEC and House filings as of 2026-10-27, dated the day the filing was made public.
Explore insider trading and ownership data
Every company we track, ranked by each kind of filing
No password to create and no card required. We store your email address, your watchlist and your preferences, nothing else.
PRIVACY & COOKIES
We track filings, not you.
Essential cookies keep you signed in and remember this choice.
Google Analytics 4 and Microsoft Clarity load only if you allow them here; they
count visits and record how pages are used. We run no advertising and never sell
data. Details in the privacy policy. Change this any time
via "Cookie settings" in the footer.